The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The pediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups.
 
Cornelis Martinus van Tilburg
Consulting or Advisory Role - Bayer; Novartis
 
Elke Pfaff
No Relationships to Disclose
 
Kristian W. Pajtler
No Relationships to Disclose
 
Karin P.S. Langenberg
No Relationships to Disclose
 
Petra Fiesel
No Relationships to Disclose
 
Barbara C. Jones
No Relationships to Disclose
 
Gnana Prakash Balasubramanian
No Relationships to Disclose
 
Sebastian Stark
No Relationships to Disclose
 
Pascal D. Johann
No Relationships to Disclose
 
Mirjam Blattner-Johnson
No Relationships to Disclose
 
Kathrin Schramm
No Relationships to Disclose
 
Natalie Jäger
No Relationships to Disclose
 
Andreas von Deimling
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bayer
Patents, Royalties, Other Intellectual Property - Patent for BRAFV600E antibody VE1 administered by the German Cancer Center (DKFZ); Patent for IDH1R132H antibody H09 administered by the German Cancer Center (DKFZ)
Travel, Accommodations, Expenses - Roche
 
Uta Dirksen
Consulting or Advisory Role - Ipsen; Lilly (Inst)
 
Angelika Freitag
No Relationships to Disclose
 
Ruth Witt
No Relationships to Disclose
 
Peter Lichter
No Relationships to Disclose
 
David T.W. Jones
No Relationships to Disclose
 
Stefan M. Pfister
No Relationships to Disclose
 
Olaf Witt
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen Research & Development; Novartis; Roche